On Western blot analysis, pFAK, in contrast to the relatively stable expression of FAK, decreased after F14 treatment in FAK-copy-gain breast cancer cells such as BT-549 and MDA-MB-453 (Figure 3A), indicating that F14 inhibits the activation of FAK. Here, PTK2 is linked to breast cancer.